메뉴 건너뛰기




Volumn 55, Issue 12, 2010, Pages 1189-1196

B-Type Natriuretic Peptide and the Effect of Ranolazine in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes. Observations From the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) Trial

Author keywords

angina; myocardial infarction; natriuretic peptides; ranolazine; unstable angina

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CALCIUM; PLACEBO; RANOLAZINE; SODIUM;

EID: 77949286901     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.09.068     Document Type: Article
Times cited : (70)

References (34)
  • 1
    • 0035807597 scopus 로고    scopus 로고
    • The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
    • de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
    • (2001) N Engl J Med , vol.345 , pp. 1014-1021
    • de Lemos, J.A.1    Morrow, D.A.2    Bentley, J.H.3
  • 2
    • 0344608881 scopus 로고    scopus 로고
    • Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST elevation MI: BNP and prognosis in TACTICS-TIMI 18
    • Morrow D.A., de Lemos J.A., Sabatine M.S., et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST elevation MI: BNP and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 41 (2003) 1264-1272
    • (2003) J Am Coll Cardiol , vol.41 , pp. 1264-1272
    • Morrow, D.A.1    de Lemos, J.A.2    Sabatine, M.S.3
  • 3
    • 0042809588 scopus 로고    scopus 로고
    • N-terminal pro brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary disease-a GUSTO IV substudy
    • James S.K., Wallentin L., Armstrong P.W., et al. N-terminal pro brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary disease-a GUSTO IV substudy. Circulation 108 (2003) 275-281
    • (2003) Circulation , vol.108 , pp. 275-281
    • James, S.K.1    Wallentin, L.2    Armstrong, P.W.3
  • 4
    • 0032546646 scopus 로고    scopus 로고
    • Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
    • Richards A.M., Nicholls M.G., Yandle T.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97 (1998) 1921-1929
    • (1998) Circulation , vol.97 , pp. 1921-1929
    • Richards, A.M.1    Nicholls, M.G.2    Yandle, T.G.3
  • 5
    • 0029948712 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N- terminal proatrial natriuretic peptide
    • Omland T., Aakvaag A., Bonarjee V.V., et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N- terminal proatrial natriuretic peptide. Circulation 93 (1996) 1963-1969
    • (1996) Circulation , vol.93 , pp. 1963-1969
    • Omland, T.1    Aakvaag, A.2    Bonarjee, V.V.3
  • 6
    • 33947314211 scopus 로고    scopus 로고
    • Use of natriuretic peptides in clinical decision-making for patients with non-ST-elevation acute coronary syndromes
    • de Lemos J.A., and Morrow D.A. Use of natriuretic peptides in clinical decision-making for patients with non-ST-elevation acute coronary syndromes. Am Heart J 153 (2007) 450-453
    • (2007) Am Heart J , vol.153 , pp. 450-453
    • de Lemos, J.A.1    Morrow, D.A.2
  • 7
    • 34247271336 scopus 로고    scopus 로고
    • National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes
    • Morrow D.A., Cannon C.P., Jesse R.L., et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 115 (2007) e356-e375
    • (2007) Circulation , vol.115
    • Morrow, D.A.1    Cannon, C.P.2    Jesse, R.L.3
  • 8
    • 33744455453 scopus 로고    scopus 로고
    • Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions
    • Chaitman B.R. Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation 113 (2006) 2462-2472
    • (2006) Circulation , vol.113 , pp. 2462-2472
    • Chaitman, B.R.1
  • 9
    • 0344608880 scopus 로고    scopus 로고
    • Intracellular Na+ regulation in cardiac myocytes
    • Bers D.M., Barry W.H., and Despa S. Intracellular Na+ regulation in cardiac myocytes. Cardiovasc Res 57 (2003) 897-912
    • (2003) Cardiovasc Res , vol.57 , pp. 897-912
    • Bers, D.M.1    Barry, W.H.2    Despa, S.3
  • 10
    • 0036801431 scopus 로고    scopus 로고
    • Defective cardiac ion channels: from mutations to clinical syndromes
    • Clancy C.E., and Kass R.S. Defective cardiac ion channels: from mutations to clinical syndromes. J Clin Invest 110 (2002) 1075-1077
    • (2002) J Clin Invest , vol.110 , pp. 1075-1077
    • Clancy, C.E.1    Kass, R.S.2
  • 11
    • 0030032681 scopus 로고    scopus 로고
    • Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts
    • McCormack J.G., Barr R.L., Wolff A.A., and Lopaschuk G.D. Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts. Circulation 93 (1996) 135-142
    • (1996) Circulation , vol.93 , pp. 135-142
    • McCormack, J.G.1    Barr, R.L.2    Wolff, A.A.3    Lopaschuk, G.D.4
  • 12
    • 34247526904 scopus 로고    scopus 로고
    • Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial
    • Morrow D.A., Scirica B.M., Karwatowska-Prokopczuk E., et al. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. JAMA 297 (2007) 1775-1783
    • (2007) JAMA , vol.297 , pp. 1775-1783
    • Morrow, D.A.1    Scirica, B.M.2    Karwatowska-Prokopczuk, E.3
  • 13
    • 33746266565 scopus 로고    scopus 로고
    • Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial
    • Morrow D.A., Scirica B.M., Karwatowska-Prokopczuk E., Skene A., McCabe C.H., and Braunwald E. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial. Am Heart J 152 (2006) 400-406
    • (2006) Am Heart J , vol.152 , pp. 400-406
    • Morrow, D.A.1    Scirica, B.M.2    Karwatowska-Prokopczuk, E.3    Skene, A.4    McCabe, C.H.5    Braunwald, E.6
  • 14
    • 11144358465 scopus 로고    scopus 로고
    • Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study
    • Wu A.H., Packer M., Smith A., et al. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem 50 (2004) 867-873
    • (2004) Clin Chem , vol.50 , pp. 867-873
    • Wu, A.H.1    Packer, M.2    Smith, A.3
  • 15
    • 28944439267 scopus 로고    scopus 로고
    • Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease
    • Morrow D.A., de Lemos J.A., Blazing M.A., et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. JAMA 294 (2005) 2866-2871
    • (2005) JAMA , vol.294 , pp. 2866-2871
    • Morrow, D.A.1    de Lemos, J.A.2    Blazing, M.A.3
  • 16
    • 35448971466 scopus 로고    scopus 로고
    • Universal definition of myocardial infarction
    • Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
    • Thygesen K., Alpert J.S., White H.D., et al., Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 28 (2007) 2525-2538
    • (2007) Eur Heart J , vol.28 , pp. 2525-2538
    • Thygesen, K.1    Alpert, J.S.2    White, H.D.3
  • 17
    • 35148850168 scopus 로고    scopus 로고
    • Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non st-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial
    • Scirica B.M., Morrow D.A., Hod H., et al. Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non st-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 116 (2007) 1647-1652
    • (2007) Circulation , vol.116 , pp. 1647-1652
    • Scirica, B.M.1    Morrow, D.A.2    Hod, H.3
  • 18
    • 0029116749 scopus 로고
    • Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction
    • Hama N., Itoh H., Shirakami G., et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92 (1995) 1558-1564
    • (1995) Circulation , vol.92 , pp. 1558-1564
    • Hama, N.1    Itoh, H.2    Shirakami, G.3
  • 19
    • 0029055445 scopus 로고
    • Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris
    • Marumoto K., Hamada M., and Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Colch) 88 (1995) 551-556
    • (1995) Clin Sci (Colch) , vol.88 , pp. 551-556
    • Marumoto, K.1    Hamada, M.2    Hiwada, K.3
  • 20
    • 8144225341 scopus 로고    scopus 로고
    • Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia
    • Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 44 (2004) 1988-1995
    • (2004) J Am Coll Cardiol , vol.44 , pp. 1988-1995
    • Sabatine, M.S.1    Morrow, D.A.2    de Lemos, J.A.3
  • 21
    • 8144219524 scopus 로고    scopus 로고
    • Detection of exercise-induced ischemia by changes in B-type natriuretic peptides
    • Foote R.S., Pearlman J.D., Siegel A.H., and Yeo K.T. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 44 (2004) 1980-1987
    • (2004) J Am Coll Cardiol , vol.44 , pp. 1980-1987
    • Foote, R.S.1    Pearlman, J.D.2    Siegel, A.H.3    Yeo, K.T.4
  • 22
    • 0033806421 scopus 로고    scopus 로고
    • Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty
    • Tateishi J., Masutani M., Ohyanagi M., and Iwasaki T. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol 23 (2000) 776-780
    • (2000) Clin Cardiol , vol.23 , pp. 776-780
    • Tateishi, J.1    Masutani, M.2    Ohyanagi, M.3    Iwasaki, T.4
  • 23
    • 33846442057 scopus 로고    scopus 로고
    • Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial)
    • Bonaca M.P., Wiviott S.D., Sabatine M.S., et al. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial). Am J Cardiol 99 (2007) 344-348
    • (2007) Am J Cardiol , vol.99 , pp. 344-348
    • Bonaca, M.P.1    Wiviott, S.D.2    Sabatine, M.S.3
  • 24
    • 0042198675 scopus 로고    scopus 로고
    • B-type natriuretic peptide in cardiovascular disease
    • de Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-322
    • (2003) Lancet , vol.362 , pp. 316-322
    • de Lemos, J.A.1    McGuire, D.K.2    Drazner, M.H.3
  • 25
    • 4043152160 scopus 로고    scopus 로고
    • Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction
    • Sadanandan S., Cannon C.P., Chekuri K., et al. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 44 (2004) 564-568
    • (2004) J Am Coll Cardiol , vol.44 , pp. 564-568
    • Sadanandan, S.1    Cannon, C.P.2    Chekuri, K.3
  • 26
    • 13744259846 scopus 로고    scopus 로고
    • N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease
    • Kragelund C., Gronning B., Kober L., Hildebrandt P., and Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352 (2005) 666-675
    • (2005) N Engl J Med , vol.352 , pp. 666-675
    • Kragelund, C.1    Gronning, B.2    Kober, L.3    Hildebrandt, P.4    Steffensen, R.5
  • 27
    • 33748420987 scopus 로고    scopus 로고
    • Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy
    • James S.K., Lindback J., Tilly J., et al. Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy. J Am Coll Cardiol 48 (2006) 1146-1154
    • (2006) J Am Coll Cardiol , vol.48 , pp. 1146-1154
    • James, S.K.1    Lindback, J.2    Tilly, J.3
  • 28
    • 33947314845 scopus 로고    scopus 로고
    • N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy
    • Windhausen F., Hirsch A., Sanders G.T., et al. N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy. Am Heart J 153 (2007) 485-492
    • (2007) Am Heart J , vol.153 , pp. 485-492
    • Windhausen, F.1    Hirsch, A.2    Sanders, G.T.3
  • 29
    • 33646923161 scopus 로고    scopus 로고
    • Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study
    • Scirica B.M., Morrow D.A., Cannon C.P., et al. Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study. J Am Coll Cardiol 47 (2006) 2326-2331
    • (2006) J Am Coll Cardiol , vol.47 , pp. 2326-2331
    • Scirica, B.M.1    Morrow, D.A.2    Cannon, C.P.3
  • 30
    • 0026771182 scopus 로고
    • A persistent sodium current in rat ventricular myocytes
    • Saint D.A., Ju Y.K., and Gage P.W. A persistent sodium current in rat ventricular myocytes. J Physiol 453 (1992) 219-231
    • (1992) J Physiol , vol.453 , pp. 219-231
    • Saint, D.A.1    Ju, Y.K.2    Gage, P.W.3
  • 32
    • 0037163064 scopus 로고    scopus 로고
    • Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure
    • Chandler M.P., Stanley W.C., Morita H., et al. Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure. Circ Res 91 (2002) 278-280
    • (2002) Circ Res , vol.91 , pp. 278-280
    • Chandler, M.P.1    Stanley, W.C.2    Morita, H.3
  • 33
    • 0036936426 scopus 로고    scopus 로고
    • Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure
    • Sabbah H.N., Chandler M.P., Mishima T., et al. Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure. J Card Fail 8 (2002) 416-422
    • (2002) J Card Fail , vol.8 , pp. 416-422
    • Sabbah, H.N.1    Chandler, M.P.2    Mishima, T.3
  • 34
    • 0036154499 scopus 로고    scopus 로고
    • Partial fatty acid oxidation inhibitors: a potentially new class of drugs for heart failure
    • Sabbah H.H., and Stanley W.C. Partial fatty acid oxidation inhibitors: a potentially new class of drugs for heart failure. Eur J Heart Fail 4 (2002) 3-6
    • (2002) Eur J Heart Fail , vol.4 , pp. 3-6
    • Sabbah, H.H.1    Stanley, W.C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.